ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Session » Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations

Date: Monday, November 9, 2015

Time: 9:00AM-11:00AM

Meeting: 2015 ACR/ARHP Annual Meeting

9:00AM-11:00AM
Abstract Number: 1278
An Underlying Diagnosis of Osteoarthritis Is Associated with Better Outcomes after Total Hip Arthroplasty Than Avascular Necrosis of Bone
9:00AM-11:00AM
Abstract Number: 1284
Burden of Illness Associated with Non-Radiographic Axial Spondyloarthritis: A European Real World Database Analysis from the Clinical and Healthcare System Perspective
9:00AM-11:00AM
Abstract Number: 1290
Burden of Rheumatoid Arthritis in the US Elderly Population: Comorbidities, Healthcare Resource Utilization, and Cost
9:00AM-11:00AM
Abstract Number: 1280
Comparison of Health Service Utilization Costs Between Aboriginal and Non-Aboriginal Patients with Rheumatoid Arthritis Requiring Biologic Therapy
9:00AM-11:00AM
Abstract Number: 1271
Cost Savings and Interest in Pediatric Rheumatology Telemedicine Visits
9:00AM-11:00AM
Abstract Number: 1267
Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF
9:00AM-11:00AM
Abstract Number: 1288
Dual Care Utilization in Patients Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry
9:00AM-11:00AM
Abstract Number: 1274
Factors That Impact Job Selection in Pediatric Rheumatology
9:00AM-11:00AM
Abstract Number: 1289
Healthcare Utilization Differences According to Sex Among Children and Adults in Medicaid with Incident Lupus Nephritis
9:00AM-11:00AM
Abstract Number: 1287
Impact of Participation in Adalimumab Patient Support Program (PSP)  on Clinical Outcomes and Predictors of PSP Utilization Among Patients with Rheumatoid Arthritis
9:00AM-11:00AM
Abstract Number: 1276
Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey
9:00AM-11:00AM
Abstract Number: 1270
Low Socioeconomic Status As a Predictor of Long-Term Direct Medical Costs Following Diagnosis of Granulomatosus with Polyangiitis: A General Population-Based Cohort Study
9:00AM-11:00AM
Abstract Number: 1285
Markers of Non-Compliance with ASAS/EULAR Management Recommendations Among Early Spa Patients: Evidence over 3 Years in the DESIR Cohort
9:00AM-11:00AM
Abstract Number: 1269
Measuring the Rheumatologist Workforce in Canada: Preliminary Results of the Stand up and be Counted Survey
9:00AM-11:00AM
Abstract Number: 1275
Pediatric Rheumatology Work Force and Patients Status in Latin America. a Snap Shot Web Based Survey
9:00AM-11:00AM
Abstract Number: 1282
Persistence with Osteoporosis Therapies in Postmenopausal Women in a Large US National Health Plan
9:00AM-11:00AM
Abstract Number: 1286
Persistent Individual and Neighborhood Poverty Are Independent Risk Factors for Accumulated Lupus Damage
9:00AM-11:00AM
Abstract Number: 1279
Racial Variation in Total Knee Replacement in a Diverse Community-Based Clinical Trial
9:00AM-11:00AM
Abstract Number: 1281
Reduction in Rural-Urban Disparity in Discharge Disposition to Home after Total Knee Arthroplasty in the U.S
9:00AM-11:00AM
Abstract Number: 1266
Rheumatologic Diagnoses, Characteristics and Needs of Somali Patients Referred to a Rheumatology Clinic Serving the Somali Population
9:00AM-11:00AM
Abstract Number: 1283
The Burden of Non-Radiographic Axial Spondyloarthritis from the Employer Perspective: A Real World European Study
9:00AM-11:00AM
Abstract Number: 1291
The Pediatric Rheumatology Workforce in 2015: A Survey of Pediatric Rheumatologists
9:00AM-11:00AM
Abstract Number: 1273
Uptake of the First Biosimilar Infliximab Since Its Approval in South Korea
9:00AM-11:00AM
Abstract Number: 1277
US Adult Rheumatologists Perspective on the Transition Process for Young Adults with Rheumatic Conditions
9:00AM-11:00AM
Abstract Number: 1272
Utilization of Ambulatory Physician Encounters, Emergency Room Visits and Hospitalizations By SLE Patients: A 13 Year Population Health Study
9:00AM-11:00AM
Abstract Number: 1268
Utilization of Viscosupplementation: 2011 – 2013
9:00AM-11:00AM
Abstract Number: 1292
What Is the Effect of TNF Inhibitors on Employment Status in Rheumatoid Arthritis Patients and What Are the Predictors of Progression to Unemployment?

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology